384 related articles for article (PubMed ID: 22266967)
1. Increased poly(ADP-ribosyl)ation in peripheral leukocytes and the reperfused myocardium tissue of rats with ischemia/reperfusion injury: prevention by 3-aminobenzamide treatment.
Zhang LQ; Qi GX; Jiang DM; Tian W; Zou JL
Shock; 2012 May; 37(5):492-500. PubMed ID: 22266967
[TBL] [Abstract][Full Text] [Related]
2. Suppression of poly (ADP-ribose) polymerase activation by 3-aminobenzamide in a rat model of myocardial infarction: long-term morphological and functional consequences.
Liaudet L; Szabó E ; Timashpolsky L; Virág L; Cziráki A; Szabó C
Br J Pharmacol; 2001 Aug; 133(8):1424-30. PubMed ID: 11498530
[TBL] [Abstract][Full Text] [Related]
3. Activation of poly(ADP-ribose) polymerase in circulating leukocytes during myocardial infarction.
Murthy KG; Xiao CY; Mabley JG; Chen M; Szabó C
Shock; 2004 Mar; 21(3):230-4. PubMed ID: 14770035
[TBL] [Abstract][Full Text] [Related]
4. Prevention of myocardial reperfusion injury by poly(ADP-ribose) synthetase inhibitor, 3-aminobenzamide, in cardioplegic solution: in vitro study of isolated rat heart model.
Yamazaki K; Miwa S; Ueda K; Tanaka S; Toyokuni S; Unimonh O; Nishimura K; Komeda M
Eur J Cardiothorac Surg; 2004 Aug; 26(2):270-5. PubMed ID: 15296882
[TBL] [Abstract][Full Text] [Related]
5. Beneficial effects of 3-aminobenzamide, an inhibitor of poly (ADP-ribose) synthetase in a rat model of splanchnic artery occlusion and reperfusion.
Cuzzocrea S; Zingarelli B; Costantino G; Szabó A; Salzman AL; Caputi AP; Szabó C
Br J Pharmacol; 1997 Jul; 121(6):1065-74. PubMed ID: 9249240
[TBL] [Abstract][Full Text] [Related]
6. Poly(ADP-ribose) polymerase activation in the reperfused myocardium.
Szabó G; Liaudet L; Hagl S; Szabó C
Cardiovasc Res; 2004 Feb; 61(3):471-80. PubMed ID: 14962478
[TBL] [Abstract][Full Text] [Related]
7. Continuous inhibition of poly(ADP-ribose) polymerase does not reduce reperfusion injury in isolated rat heart.
Nishizawa K; Yanagida S; Yamagishi T; Takayama E; Bessho M; Kusuhara M; Adachi T; Ohsuzu F
J Cardiovasc Pharmacol; 2013 Jul; 62(1):99-105. PubMed ID: 23846805
[TBL] [Abstract][Full Text] [Related]
8. Post-treatment at 12 or 18 hours with 3-aminobenzamide ameliorates retinal ischemia-reperfusion damage.
Chiang SK; Lam TT
Invest Ophthalmol Vis Sci; 2000 Sep; 41(10):3210-4. PubMed ID: 10967085
[TBL] [Abstract][Full Text] [Related]
9. Ischemic brain injury is mediated by the activation of poly(ADP-ribose)polymerase.
Endres M; Wang ZQ; Namura S; Waeber C; Moskowitz MA
J Cereb Blood Flow Metab; 1997 Nov; 17(11):1143-51. PubMed ID: 9390645
[TBL] [Abstract][Full Text] [Related]
10. Protective effects of caspase-9 and poly(ADP-ribose) polymerase inhibitors on ischemia-reperfusion-induced myocardial injury.
Sodhi RK; Singh M; Singh N; Jaggi AS
Arch Pharm Res; 2009 Jul; 32(7):1037-43. PubMed ID: 19641885
[TBL] [Abstract][Full Text] [Related]
11. Distribution of Poly(ADP-ribosyl)ation and cell death after cerebral ischemia in the neonatal rat.
Joly LM; Benjelloun N; Plotkine M; Charriaut-Marlangue C
Pediatr Res; 2003 May; 53(5):776-82. PubMed ID: 12621128
[TBL] [Abstract][Full Text] [Related]
12. Inhibitors of poly (ADP-ribose) polymerase ameliorate myocardial reperfusion injury by modulation of activator protein-1 and neutrophil infiltration.
Kaplan J; O'Connor M; Hake PW; Zingarelli B
Shock; 2005 Mar; 23(3):233-8. PubMed ID: 15718920
[TBL] [Abstract][Full Text] [Related]
13. Effects of 3-aminobenzamide on expressions of poly (ADP ribose) polymerase and apoptosis inducing factor in cardiomyocytes of rats with acute myocardial infarction.
Zhao YJ; Wang JH; Fu B; Ma MX; Li BX; Huang Q; Yang BF
Chin Med J (Engl); 2009 Jun; 122(11):1322-7. PubMed ID: 19567145
[TBL] [Abstract][Full Text] [Related]
14. Imidazoquinolinone, imidazopyridine, and isoquinolindione derivatives as novel and potent inhibitors of the poly(ADP-ribose) polymerase (PARP): a comparison with standard PARP inhibitors.
Eltze T; Boer R; Wagner T; Weinbrenner S; McDonald MC; Thiemermann C; Bürkle A; Klein T
Mol Pharmacol; 2008 Dec; 74(6):1587-98. PubMed ID: 18809672
[TBL] [Abstract][Full Text] [Related]
15. Inhibitors of poly(ADP-ribose) polymerase modulate signal transduction pathways and secondary damage in experimental spinal cord trauma.
Genovese T; Mazzon E; Muià C; Patel NS; Threadgill MD; Bramanti P; De Sarro A; Thiemermann C; Cuzzocrea S
J Pharmacol Exp Ther; 2005 Feb; 312(2):449-57. PubMed ID: 15452194
[TBL] [Abstract][Full Text] [Related]
16. The role of Akt and mitogen-activated protein kinase systems in the protective effect of poly(ADP-ribose) polymerase inhibition in Langendorff perfused and in isoproterenol-damaged rat hearts.
Pálfi A; Tóth A; Kulcsár G; Hantó K; Deres P; Bartha E; Halmosi R; Szabados E; Czopf L; Kálai T; Hideg K; Sümegi B; Tóth K
J Pharmacol Exp Ther; 2005 Oct; 315(1):273-82. PubMed ID: 15951400
[TBL] [Abstract][Full Text] [Related]
17. Myocardial ischemic preconditioning in rodents is dependent on poly (ADP-ribose) synthetase.
Liaudet L; Yang Z; Al-Affar EB; Szabó C
Mol Med; 2001 Jun; 7(6):406-17. PubMed ID: 11474134
[TBL] [Abstract][Full Text] [Related]
18. Enhanced poly(ADP-ribosyl)ation after focal ischemia in rat brain.
Tokime T; Nozaki K; Sugino T; Kikuchi H; Hashimoto N; Ueda K
J Cereb Blood Flow Metab; 1998 Sep; 18(9):991-7. PubMed ID: 9740102
[TBL] [Abstract][Full Text] [Related]
19. Effects of 3-aminobenzamide on unilateral testicular ischemia-reperfusion injury: what is the role of PARP inhibition?
Hekimoglu A; Kurcer Z; Aral F; Baba F; Atessahin A; Sakin F
Can J Physiol Pharmacol; 2010 Dec; 88(12):1123-9. PubMed ID: 21164558
[TBL] [Abstract][Full Text] [Related]
20. Poly(ADP-ribosyl)ation enhancement in brain cell nuclei is associated with diabetic neuropathy.
Kuchmerovska T; Shymanskyy I; Donchenko G; Kuchmerovskyy M; Pakirbaieva L; Klimenko A
J Diabetes Complications; 2004; 18(4):198-204. PubMed ID: 15207836
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
